Shionogi & Co. Ltd.

In News

Fierce Pharma Asia—China biotech deal spree rolls on; Shionogi buys Tanabe's ALS business - Fierce Pharma

Fierce Pharma - Jan 09, 2026

Shionogi moves to acquire global rights to Radicava for ALS - ALS News Today

ALS News Today - Jan 08, 2026

Shionogi & Co., Ltd.'s (TSE:4507) Shares May Have Run Too Fast Too Soon - simplywall.st

simplywall.st - Jan 10, 2026

Shionogi sets up manufacturing subsidiary - The Pharma Letter

The Pharma Letter - Jan 08, 2026

Recognized with the Double A List for Leadership in Corporate Transparency and Performance on Climate Change and Water Security by CDP - Shionogi Inc.

Shionogi Inc. - Dec 11, 2025

Shionogi to buy Jersey City pharma for $2.5B - NJBIZ

NJBIZ - Dec 23, 2025

Tanabe Pharma America Announces Transfer of RADICAVA® Business to Shionogi - PR Newswire

PR Newswire - Dec 22, 2025

Shionogi awarded $375m from HHS for preventative Covid-19 injectable - MSN

MSN - Jan 07, 2026

Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA - Business Wire

Business Wire - Dec 22, 2025

Shionogi shells out $2.5B for Mitsubishi Tanabe's ALS drug - FirstWord

FirstWord - Dec 22, 2025

Shionogi in Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® and IV RADICAVA - Cleary Gottlieb

Cleary Gottlieb - Dec 23, 2025

FDA Accepts Shionogi’s NDA for Ensitrelvir Oral Antiviral in COVID-19 Postexposure Prevention - Contagion Live

Contagion Live - Sep 02, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment